 Hanan Elajaili
Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electron Spin Resonance Spectroscopy | 18 | 2023 | 91 | 3.040 |
Why?
| | Reactive Oxygen Species | 5 | 2025 | 593 | 1.590 |
Why?
| | Nitrogen Oxides | 9 | 2023 | 52 | 1.440 |
Why?
| | Superoxides | 4 | 2025 | 201 | 1.200 |
Why?
| | Acute Lung Injury | 3 | 2023 | 279 | 0.960 |
Why?
| | Quinones | 2 | 2015 | 9 | 0.950 |
Why?
| | Superoxide Dismutase | 3 | 2025 | 342 | 0.940 |
Why?
| | Oxidation-Reduction | 6 | 2023 | 1028 | 0.940 |
Why?
| | Hydroxylamine | 1 | 2023 | 7 | 0.860 |
Why?
| | Mice, Inbred C57BL | 7 | 2025 | 5438 | 0.860 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2025 | 183 | 0.860 |
Why?
| | Wound Healing | 1 | 2025 | 305 | 0.790 |
Why?
| | Lung | 8 | 2025 | 3927 | 0.640 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4056 | 0.600 |
Why?
| | Electrons | 2 | 2014 | 77 | 0.560 |
Why?
| | Nails | 1 | 2016 | 11 | 0.530 |
Why?
| | Radiometry | 1 | 2016 | 47 | 0.520 |
Why?
| | Biological Assay | 1 | 2016 | 118 | 0.500 |
Why?
| | Temperature | 1 | 2019 | 635 | 0.490 |
Why?
| | Disulfides | 1 | 2015 | 97 | 0.480 |
Why?
| | Inflammation | 2 | 2025 | 2735 | 0.470 |
Why?
| | Alcohols | 1 | 2014 | 29 | 0.460 |
Why?
| | Oxidative Stress | 5 | 2025 | 1265 | 0.420 |
Why?
| | Sulfhydryl Compounds | 1 | 2015 | 187 | 0.420 |
Why?
| | Mice | 12 | 2025 | 16905 | 0.360 |
Why?
| | Glutathione | 2 | 2024 | 347 | 0.300 |
Why?
| | Bleomycin | 2 | 2021 | 242 | 0.300 |
Why?
| | Animals | 13 | 2025 | 35286 | 0.270 |
Why?
| | Free Radicals | 3 | 2015 | 105 | 0.260 |
Why?
| | Kidney | 2 | 2024 | 1384 | 0.240 |
Why?
| | Acute Kidney Injury | 2 | 2024 | 789 | 0.240 |
Why?
| | Pneumonia, Staphylococcal | 1 | 2025 | 20 | 0.240 |
Why?
| | Cerium | 2 | 2021 | 14 | 0.230 |
Why?
| | Cell Communication | 1 | 2025 | 300 | 0.210 |
Why?
| | Oxygen | 4 | 2016 | 914 | 0.210 |
Why?
| | Mitochondria | 2 | 2020 | 876 | 0.210 |
Why?
| | Fibroblasts | 2 | 2025 | 947 | 0.200 |
Why?
| | Uncoupling Protein 2 | 1 | 2022 | 8 | 0.200 |
Why?
| | Antimycin A | 2 | 2020 | 13 | 0.200 |
Why?
| | Blood Platelets | 1 | 2025 | 380 | 0.190 |
Why?
| | Deuterium | 4 | 2014 | 87 | 0.190 |
Why?
| | Myofibroblasts | 1 | 2022 | 121 | 0.180 |
Why?
| | Succinate Dehydrogenase | 1 | 2021 | 44 | 0.180 |
Why?
| | Phantoms, Imaging | 3 | 2016 | 137 | 0.170 |
Why?
| | Catechin | 1 | 2020 | 24 | 0.170 |
Why?
| | Lipopolysaccharides | 1 | 2023 | 877 | 0.160 |
Why?
| | Neutrophils | 1 | 2025 | 1207 | 0.160 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 22 | 0.160 |
Why?
| | Reperfusion Injury | 1 | 2022 | 271 | 0.160 |
Why?
| | Cell Compartmentation | 1 | 2019 | 52 | 0.150 |
Why?
| | Lung Injury | 1 | 2021 | 210 | 0.150 |
Why?
| | RAW 264.7 Cells | 1 | 2019 | 49 | 0.150 |
Why?
| | Mice, Knockout | 2 | 2023 | 2871 | 0.150 |
Why?
| | Equipment Failure Analysis | 2 | 2016 | 130 | 0.150 |
Why?
| | Algorithms | 3 | 2015 | 1613 | 0.150 |
Why?
| | Electromagnetic Fields | 2 | 2015 | 23 | 0.150 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2019 | 79 | 0.150 |
Why?
| | Spin Labels | 3 | 2014 | 46 | 0.150 |
Why?
| | Energy Metabolism | 1 | 2024 | 873 | 0.150 |
Why?
| | Glioma | 1 | 2022 | 347 | 0.150 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 332 | 0.140 |
Why?
| | Hyaluronic Acid | 1 | 2020 | 214 | 0.140 |
Why?
| | Macrophages | 1 | 2025 | 1481 | 0.140 |
Why?
| | Nanoparticles | 1 | 2021 | 374 | 0.140 |
Why?
| | Equipment Design | 2 | 2016 | 512 | 0.140 |
Why?
| | Molecular Structure | 2 | 2017 | 478 | 0.140 |
Why?
| | Sensitivity and Specificity | 3 | 2016 | 1833 | 0.130 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2016 | 541 | 0.130 |
Why?
| | Carboxylic Acids | 1 | 2017 | 32 | 0.130 |
Why?
| | Triacetoneamine-N-Oxyl | 2 | 2014 | 2 | 0.130 |
Why?
| | Microwaves | 1 | 2016 | 35 | 0.130 |
Why?
| | Cattle | 1 | 2019 | 977 | 0.130 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2019 | 644 | 0.130 |
Why?
| | Liver | 1 | 2024 | 1839 | 0.120 |
Why?
| | Pyrroles | 1 | 2017 | 201 | 0.120 |
Why?
| | Antioxidants | 1 | 2019 | 558 | 0.120 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2014 | 537 | 0.120 |
Why?
| | Pneumonia | 1 | 2021 | 616 | 0.120 |
Why?
| | Spin Trapping | 1 | 2014 | 3 | 0.120 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2022 | 634 | 0.120 |
Why?
| | Protons | 1 | 2015 | 80 | 0.120 |
Why?
| | Methanol | 1 | 2014 | 35 | 0.110 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1085 | 0.110 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2015 | 144 | 0.110 |
Why?
| | MicroRNAs | 1 | 2021 | 676 | 0.110 |
Why?
| | Hydrogen Bonding | 1 | 2014 | 149 | 0.110 |
Why?
| | Hydroxyl Radical | 1 | 2014 | 91 | 0.110 |
Why?
| | Magnetics | 1 | 2014 | 43 | 0.110 |
Why?
| | Transducers | 1 | 2014 | 27 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2016 | 3077 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 901 | 0.110 |
Why?
| | Molecular Imaging | 1 | 2014 | 54 | 0.110 |
Why?
| | Indicators and Reagents | 4 | 2014 | 109 | 0.100 |
Why?
| | Models, Biological | 1 | 2020 | 1722 | 0.100 |
Why?
| | Hypoxia | 1 | 2020 | 1084 | 0.100 |
Why?
| | Male | 6 | 2024 | 63456 | 0.100 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2045 | 0.090 |
Why?
| | Ethanol | 1 | 2014 | 589 | 0.080 |
Why?
| | Nitrogen Radioisotopes | 3 | 2014 | 5 | 0.080 |
Why?
| | Anisotropy | 3 | 2013 | 73 | 0.070 |
Why?
| | Hypertension, Pulmonary | 1 | 2020 | 1894 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2025 | 2117 | 0.070 |
Why?
| | Signal Transduction | 2 | 2020 | 4919 | 0.070 |
Why?
| | Neutrophil Infiltration | 1 | 2025 | 105 | 0.060 |
Why?
| | Platelet Activation | 1 | 2025 | 91 | 0.060 |
Why?
| | HIV Infections | 1 | 2019 | 2721 | 0.060 |
Why?
| | Time Factors | 1 | 2014 | 6541 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3386 | 0.050 |
Why?
| | Nitrogen Isotopes | 2 | 2013 | 58 | 0.050 |
Why?
| | Glycolysis | 1 | 2024 | 311 | 0.050 |
Why?
| | Female | 3 | 2025 | 68494 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2022 | 76 | 0.050 |
Why?
| | Solutions | 2 | 2012 | 150 | 0.050 |
Why?
| | Humans | 8 | 2022 | 129144 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 232 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2025 | 434 | 0.040 |
Why?
| | Ischemia | 1 | 2024 | 405 | 0.040 |
Why?
| | Metabolome | 1 | 2024 | 338 | 0.040 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2022 | 215 | 0.040 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2020 | 41 | 0.040 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2020 | 8 | 0.040 |
Why?
| | Cell Respiration | 1 | 2020 | 98 | 0.040 |
Why?
| | Electron Transport Complex I | 1 | 2020 | 39 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2021 | 179 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 520 | 0.040 |
Why?
| | Antioxidant Response Elements | 1 | 2019 | 7 | 0.040 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 102 | 0.040 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2019 | 11 | 0.040 |
Why?
| | Sirtuin 3 | 1 | 2020 | 58 | 0.040 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2019 | 32 | 0.040 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2020 | 203 | 0.040 |
Why?
| | Heme Oxygenase-1 | 1 | 2019 | 62 | 0.040 |
Why?
| | Metabolomics | 1 | 2024 | 652 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 234 | 0.040 |
Why?
| | Water | 2 | 2012 | 440 | 0.040 |
Why?
| | Sulfonamides | 1 | 2022 | 495 | 0.040 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 400 | 0.040 |
Why?
| | Protein Kinases | 1 | 2020 | 318 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2022 | 711 | 0.040 |
Why?
| | HIV | 1 | 2019 | 227 | 0.040 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2020 | 259 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2019 | 591 | 0.030 |
Why?
| | Up-Regulation | 1 | 2020 | 838 | 0.030 |
Why?
| | Radionuclide Imaging | 1 | 2016 | 122 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 954 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 1964 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2017 | 435 | 0.030 |
Why?
| | Signal-To-Noise Ratio | 1 | 2015 | 68 | 0.030 |
Why?
| | Cyclic N-Oxides | 1 | 2014 | 29 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 1000 | 0.030 |
Why?
| | Blood Pressure | 1 | 2022 | 1736 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2022 | 3186 | 0.030 |
Why?
| | Muramidase | 1 | 2014 | 77 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2019 | 746 | 0.030 |
Why?
| | Pulmonary Artery | 1 | 2020 | 1095 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2775 | 0.030 |
Why?
| | Image Enhancement | 1 | 2014 | 167 | 0.030 |
Why?
| | Viscosity | 1 | 2013 | 90 | 0.030 |
Why?
| | Apoptosis | 1 | 2022 | 2491 | 0.030 |
Why?
| | Solvents | 1 | 2013 | 108 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2020 | 2368 | 0.020 |
Why?
| | Models, Molecular | 1 | 2017 | 1485 | 0.020 |
Why?
| | Isotope Labeling | 1 | 2011 | 74 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 740 | 0.020 |
Why?
| | Models, Statistical | 1 | 2013 | 623 | 0.020 |
Why?
| | Aged | 1 | 2022 | 21997 | 0.010 |
Why?
|
|
Elajaili's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|